Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pardo

Showing results (271-280 of 274) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 274 results.
Annals of Human Genetics|February 12, 1998
Genetic history of cystic fibrosis mutations in Italy. I. Regional distributionS Rendine, F Calafell, N Cappello, et al.
The British Journal of Surgery|August 20, 2019
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trialB Garlipp, P Gibbs, G A Van Hazel, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Pageof 28

Showing results (271-280 of 274) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 274 results.
Annals of Human Genetics|February 12, 1998
Genetic history of cystic fibrosis mutations in Italy. I. Regional distributionS Rendine, F Calafell, N Cappello, et al.
The British Journal of Surgery|August 20, 2019
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trialB Garlipp, P Gibbs, G A Van Hazel, et al.
ESMO Open|October 1, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trialE Seguí, F Brasó-Maristany, T Pascual, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Pageof 28